Here's the presentation David Einhorn just gave to a room of elite hedge fund managers
In it, he explained his long thesis for pharmaceutical giant, Bayer.
Last year Bayer spun off its chemicals company, Covestro, and then in September announced a deal to take over seed-maker Monsanto.
That deal is pending approval from a dizzying number of regulators around the world.
Now, here's the crux of why Einhorn likes Bayer in all of this:
"Whether they make it to the altar, or get thwarted along the way, there's going to be a celebration for Bayer shareholders either way. With cake. And we like cake," he said.
Scroll down to get his full take on why.